About
Oncology and Neuromodulation Drug Delivery
Areas of Focus
Categories
Drug Delivery DeviceBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
600
By Phase
PHASE4: 1NA: 1PHASE3: 1
By Status
UNKNOWN: 2SUSPENDED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05875610Lead Sponsor
Preventive Approach Using Venlafaxine
PHASE4Unknown
60 participants
Started: May 1, 2023 · Completed: Dec 1, 2023
NCT02742428Lead Sponsor
Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer
NASuspended
40 participants
Started: Jan 31, 2018 · Completed: Mar 31, 2020
NCT02690636Collaborator
Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer
PHASE3Unknown
500 participants
Started: Jan 31, 2016 · Completed: Apr 30, 2021
Locations (1)
Headquarters
Wellesley, MA, United States
Map
Loading map...